Enifer
PrivateLast Round
Series B
May 23, 2024
Total Funding Raised
$55.23M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Enifer operates in Healthcare & Life Sciences and is based in Espoo. Its latest recorded funding round was a Series B round in May 2024.
Enifer is a biotechnology company that produces mycoprotein ingredients from food industry byproducts using a fungal fermentation process.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Circular Economy, Sustainable Materials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enifer Comparables
Compare Enifer with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| The Protein Brewery | 88% | |
| MOA Foodtech | 85% | |
| ODS Protein | 85% |
For institutional investors. Book with your work email.
Enifer Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 23, 2024 | ||||
| Debt | May 23, 2024 | ||||
| Grant | Jan 10, 2024 | ||||
| Series A | Apr 19, 2023 | ||||
| Grant | Dec 19, 2021 | ||||
Grant | Oct 29, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Enifer Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Finnish Climate Fund | Debt, Series B |
| Tesi | Series A |
| Taaleri Bioindustry I | Series B |
| Business Finland | Series B, Grant |
| European Commission | Grant |
| Aqua-Spark | Series A |
| Nordic Foodtech VC | Series A, Series B, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 173% MoM, reaching 2.4K.
- Mar 24, 2026
Opening US offices to target food manufacturers while scaling production in Finland.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- expands_facilitiesOct 21, 2026
Enifer's first commercial plant in Kantvik, Kirkkonummi enters commissioning in Sep '26, with capacity for up to 3,000 tonnes of PEKILO annually and full-scale production planned for 2027.
- invests_into_assetsOct 21, 2026
Enifer commissions a 3,000-ton Pekilo factory and plans to begin full-scale production in 2027.
For institutional investors. Book with your work email.
Enifer Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Enifer's valuation, stock price, and market status.
Is Enifer a public or private company?
Enifer is a private company.
What is the current stock price of Enifer?
Enifer is a private company, so its shares have no public market price. Caplight tracks Enifer's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Enifer worth (valuation)?
Valuation information for Enifer is not publicly available.
Can I buy Enifer stock?
Enifer shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Enifer's last funding round?
Enifer's most recent funding round was Series B on May 23, 2024.
Who are the main investors in Enifer?
Key investors in Enifer include Taaleri Bioindustry I, Aqua-Spark, Nordic Foodtech VC.
Will Enifer IPO soon?
No public IPO plans have been announced for Enifer.
How can I track Enifer secondary market activity?
Caplight tracks bids, offers, and trades in Enifer's shares on secondary markets.